Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ivana Melgar"'
Autor:
Alexey V Danilov, Alexandra Muir, Ivana Melgar, Sandrine Puverel, Peter Sportelli, Hari P. Miskin, Lu Chen, Geoffrey Shouse
Publikováno v:
Blood. 140:3633-3634
Autor:
Matthew G. Mei, Hun Ju Lee, Joycelynne M. Palmer, Robert Chen, Ni-Chun Tsai, Lu Chen, Kathryn McBride, D. Lynne Smith, Ivana Melgar, Joo Y. Song, Kimberley-Jane Bonjoc, Saro Armenian, Mary Nwangwu, Peter P. Lee, Jasmine Zain, Liana Nikolaenko, Leslie Popplewell, Auayporn Nademanee, Ammar Chaudhry, Steven Rosen, Larry Kwak, Stephen J. Forman, Alex F. Herrera
Publikováno v:
Blood. 139(25)
This phase 2 trial evaluated PET-adapted nivolumab alone or in combination with ifosfamide, carboplatin, and etoposide (NICE) as first salvage therapy and bridge to autologous hematopoietic cell transplantation (AHCT) in relapsed/refractory (RR) clas
Autor:
Matthew S. Davids, Adam Kittai, Brandy Gonzales, Leslie Popplewell, Geoffrey Shouse, Alexey V. Danilov, Kirsten Orand, Tanya Siddiqi, Lili Wang, Lu Chen, Alexandra Muir, Sandrine Puverel, Ivana Melgar
Publikováno v:
Blood. 138:3558-3558
Background. Despite advances in targeted and cellular therapy, outcomes among patients with RT and tNHL remain dismal. Copanlisib (COPA) is a selective, small molecule, PI3K inhibitor which preferentially targets the p110αδ isoforms . COPA has show